IN190822B - - Google Patents

Info

Publication number
IN190822B
IN190822B IN3825DE1998A IN190822B IN 190822 B IN190822 B IN 190822B IN 3825DE1998 A IN3825DE1998 A IN 3825DE1998A IN 190822 B IN190822 B IN 190822B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Girish Sahni
Rajesh Kumar
Chaiti Roy
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Priority to IN3825DE1998 priority Critical patent/IN190822B/en
Priority to EP99310541A priority patent/EP1024192B1/en
Priority to US09/940,235 priority patent/US7163817B2/en
Priority to US10/631,558 priority patent/US7250503B2/en
Publication of IN190822B publication Critical patent/IN190822B/en
Priority to US11/605,480 priority patent/US20070287660A1/en
Priority to US11/781,927 priority patent/US8143027B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153—Streptokinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
IN3825DE1998 1998-12-24 1998-12-24 IN190822B (h)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IN3825DE1998 IN190822B (h) 1998-12-24 1998-12-24
EP99310541A EP1024192B1 (en) 1998-12-24 1999-12-23 Clot-specific streptokinase proteins possessing altered plasminogen activation characteristics and a process for the preparation of said proteins
US09/940,235 US7163817B2 (en) 1998-12-24 2001-08-27 Clot-specific streptokinase proteins possessing altered plasminogen activation characteristics and a process for their preparation
US10/631,558 US7250503B2 (en) 1998-12-24 2003-07-31 Nucleic acid molecules encoding clot-specific streptokinase fusion proteins possessing altered plasminogen activation characteristics
US11/605,480 US20070287660A1 (en) 1998-12-24 2006-11-29 Novel clot-specific steptokinase proteins possessing altered plasminogen activation-characteristics and a process for the preparation of said proteins
US11/781,927 US8143027B2 (en) 1998-12-24 2007-07-23 Method of making a plasminogen activator polypeptide with clot-specific streptokinase activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3825DE1998 IN190822B (h) 1998-12-24 1998-12-24

Publications (1)

Publication Number Publication Date
IN190822B true IN190822B (h) 2003-08-23

Family

ID=11092811

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3825DE1998 IN190822B (h) 1998-12-24 1998-12-24

Country Status (3)

Country Link
US (4) US7163817B2 (h)
EP (1) EP1024192B1 (h)
IN (1) IN190822B (h)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080171362A1 (en) * 1998-12-24 2008-07-17 Girish Sahni Polynucleotides Encoding Proteins with Clot-Specific Streptokinase Activity

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1380290A1 (en) * 2002-07-09 2004-01-14 Universitair Medisch Centrum Utrecht Cross-beta structure pathway and its therapeutic relevance
US20070003552A1 (en) * 2002-07-09 2007-01-04 Gebbink Martijn F B Cross-beta structure comprising amyloid binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity and method for interfering with blood coagulation
US20090202980A1 (en) * 2005-03-21 2009-08-13 Crossbeta Biosciences B.V. Cross-Beta Structure Comprising Amyloid Binding Proteins and Methods for Detection of the Cross-Beta Structure, for Modulating Cross-Beta Structures Fibril Formation and for Modulating Cross-Beta Structure-Mediated Toxicity and Method for Interfering With Blood Coagulation
EP2386861A3 (en) 2005-07-13 2012-07-18 Crossbeta Biosciences B.V. Cross-ß structure binding compounds
EP1907864A2 (en) * 2005-07-13 2008-04-09 Crossbeta Biosciences B.V. METHODS FOR DETERMINING THE EFFECT OF A TREATMENT ON THE CROSS-ß STRUCTURE CONTENT OF A PROTEIN; SELECTION OF TREATMENTS AND USES THEREOF
US8114832B2 (en) * 2005-07-13 2012-02-14 Crossbeta Biosciences B.V. Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
EP2007800A1 (en) * 2006-03-17 2008-12-31 Crossbeta Biosciences B.V. Methods of binding of cross-beta structures by chaperones
EP2058001A1 (en) * 2007-11-08 2009-05-13 Crossbeta Biosciences B.V. Enhancement of immunogenicity of antigens
EP2058000A1 (en) * 2007-11-08 2009-05-13 Crossbeta Biosciences B.V. Immunogenic compositions capable of activating T cells
AR071169A1 (es) 2008-03-31 2010-06-02 Council Scient Ind Res Variantes de la estreptoquinasa que contienen cisteina y sus formas covalentemente modificadas
CN103179982A (zh) 2010-08-05 2013-06-26 科学与工业研究委员会 具有溶血栓和抗凝血性质的蛋白融合构建体
US20130023912A1 (en) 2010-12-31 2013-01-24 Volcano Corporation Multiple Sclerosis Therapeutic Methods Using Therapeutic Cutting Devices and Systems
CA2988553C (en) 2015-06-08 2022-02-15 The University Of Chicago Bipyramid-templated synthesis of monodisperse noble metal nanocrystals
WO2017072791A1 (en) 2015-10-26 2017-05-04 Council Of Scientific & Industrial Research A genetically modified yeast cell and improved process for production of clot-specific streptokinase

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187098A (en) 1984-03-02 1993-02-16 Board Of Regents Of The University Of Oklahoma DNA encoding hybrid streptokinases with plasminogen fibrin binding domains
GB8628398D0 (en) * 1986-11-27 1986-12-31 Central Blood Lab Authority Pharmaceutically-active conjugates
ZA879286B (en) * 1986-12-16 1988-10-26 Smith Kline Rit New plasminogen activators
CA1327161C (en) * 1987-09-01 1994-02-22 Mitsugu Kobayashi Lyophilized pharmaceutical composition of neocarzinostatin derivative
US5270030A (en) 1988-12-29 1993-12-14 Bio-Technology General Corp. Fibrin binding domain polypeptide and method of producing
US5679320A (en) * 1988-12-29 1997-10-21 Bio-Technology General Corp. Fibrin binding domain polypeptides and uses and methods of producing same
EP0397366A1 (en) * 1989-05-09 1990-11-14 The Board Of Regents Of The University Of Oklahoma Hybrid streptokinases with fibrin binding domains and methods for the synthesis of same
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
US5772996A (en) * 1990-08-03 1998-06-30 Public Health Laboratory Service Board Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax
US6054312A (en) * 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
IN190822B (h) * 1998-12-24 2003-08-23 Council Scient Ind Res
US20050027569A1 (en) * 2003-07-31 2005-02-03 Sohrab Gollogly Systems and methods for documentation of encounters and communications regarding same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080171362A1 (en) * 1998-12-24 2008-07-17 Girish Sahni Polynucleotides Encoding Proteins with Clot-Specific Streptokinase Activity
US8143027B2 (en) * 1998-12-24 2012-03-27 Council Of Scientific & Industrial Research Of Rafi Marg Method of making a plasminogen activator polypeptide with clot-specific streptokinase activity

Also Published As

Publication number Publication date
US20030059921A1 (en) 2003-03-27
US20080171362A1 (en) 2008-07-17
US20050260598A1 (en) 2005-11-24
EP1024192A2 (en) 2000-08-02
EP1024192B1 (en) 2004-11-17
US7250503B2 (en) 2007-07-31
US20070287660A1 (en) 2007-12-13
US8143027B2 (en) 2012-03-27
US7163817B2 (en) 2007-01-16
EP1024192A3 (en) 2000-11-15

Similar Documents

Publication Publication Date Title
BE2012C041I2 (h)
BE2011C024I2 (h)
DE59914668D1 (h)
BRPI9917863A2 (h)
BY4408C1 (h)
BY6371C1 (h)
CL1998003164A1 (h)
CN3072760S (h)
CN3072761S (h)
CN3073550S (h)
CN3073964S (h)
CN3074052S (h)
CN3074158S (h)
CN3074474S (h)
CN3074547S (h)
CN3074693S (h)
CN3074906S (h)
CN3074964S (h)
CN3075297S (h)
CN3075591S (h)
CN3077125S (h)
CN3077688S (h)
CN3077738S (h)
CN3077894S (h)
CN3078314S (h)